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Ginseng contains an extraordinarily complex mixture of chemical constituents 
that can vary with the species used, the place of origin, and the growing condi-
tions. Various computational analyses which include genomics, transcriptomics, 
proteomics and bioinformatics have been used to study ginseng plant. A genome-
scale metabolic network offers a holistic view of ginsenoside biosynthesis, 
helps to predict genes associated with the production of pharmacologically vital 
dammarane-type ginsenosides, and provides insight for improving medicinal 
values of ginseng by genomics-based breeding. The draft genomic architecture of 
tetraploid P. ginseng cultivar (cv.) Chunpoong (ChP) by de novo genome assembly, 
was found to be 2.98 Gbp and consist of 59,352 annotated genes. Presently, bioin-
formatics exploration of ginseng includes studies on its P-glycoproteins, the impact 
of cytochrome P-450 on ginseng pharmacokinetics, as well as target prediction and 
differential gene expression network analyses. This study applauded Betasitosterol 
and Daucosterin as ginseng bioactive constituents that have several potential 
pharmacological effects in human, by modulating several proteins which include 
androgen receptor, HMG-CoA reductase, interlukin-2, and consequently impact 
the signaling cascade of several kinases such as mitogen-activated protein kinases 
(MAPKs), as well as many transcription factors such as polycomb protein SUZ12.
Keywords: Ginseng, bioinformatics, transcriptomics, genomics, bioactive, 
pharmacokinetics
1. Introduction
Ginseng is a slow-growing, deciduous, perennial plant of the Araliaceae family 
which includes Panax ginseng (Renshen, Chinese or Korean ginseng), Panax japonicus 
(Japanese ginseng) and Panax quinquefolius (Xiyangshen, American ginseng) among 
others [1]. Ginseng contains an extraordinarily complex mixture of chemical con-
stituents that can vary with the species used, the place of origin, and the growing 
conditions [2]. Ginsengs has found therapeutic application such as anti-inflammatory, 
anti-haemostatic, antioxidant, anticancer, anti-diabetic, antiaging, anti-depressive, 
immunomodulatory, analgesic, neuroprotection, memory and learning enhancement 
effects in animals and humans [1, 3–7]. Various computational analyses which include 
genomics, transcriptomics, proteomics and bioinformatics have been used to study 
ginseng plant [4, 8–10].
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1.1 Ginseng genomics and biosynthesis of ginsenosides
A genome-scale metabolic network offers a holistic view of ginsenoside biosyn-
thesis, helps to predict genes associated with the production of pharmacologically 
vital dammarane-type ginsenosides, and provides insight for improving medicinal 
values of ginseng by genomics-based breeding [11]. The draft genomic architecture 
of tetraploid P. ginseng cultivar (cv.) Chunpoong, by de novo genome assembly, 
was reported to be 2.98 Gbp and consist of 59,352 annotated genes [11]. Recently, a 
dynamic database was built that integrates a draft genome sequence, transcriptome 
profiles, and annotation datasets of ginseng, which is publicly available (http://gin-
sengdb.snu.ac.kr/) for the use of scientific community around the globe for exploring 
the valuable resources for a range of research fields related to P. ginseng and few other 
species [4]. Transcriptome analysis has identified 100 Panax ginseng cytochrome P450 
(PgCYP) genes, whose expressions were significantly correlated with variation of 
nine mono- and total-ginsenoside contents, while further association study identified 
five SNPs and three InDels from six PgCYP genes that were significantly associated 
with the ginsenoside contents in the four-year-old roots of 42 genotypes [9].
2. Ginsenosides: structure, pharmacokinetics and mechanism
Ginsenosides are specific types of triterpene saponin, a broad group of chemical 
compounds. Ginsenosides are found nearly exclusively in Panax species (ginseng) 
and up to now more than 150 naturally occurring ginsenosides have been isolated 
from different organs of ginseng [12]. Ginsenosides appear to be responsible for 
most of the activities of ginseng including anti-diabetic, anti-allergic, anticarcino-
genic, anti-inflammatory, anti-atherosclerotic, antihypertensive, and immuno-
modulatory effects as well as anti-stress activity and effects on the central nervous 
system [6]. The structures of ginsenosides Rb1 and Rg1 are shown in Figure 1.
2.1 Structure of ginsenosides
Shi et al. [13] have reported that the seven major ginsenosides (Rg1, Re, Rb1, Rc, 
Rb2, Rb3 and Rd) were present in various parts of Chinese ginseng of various ages. 
Ginsenoside content is higher in the leaf and root hair but lower in the stem than 
that in other parts of the plant and that the total content of ginsenosides in the leaf 
decreases with age [1, 13]. Ginsenosides are divided into three main categories, the 
20(S)-protopanaxadiol, 20(S)-proto- panaxatriol and oleanane families according 
Figure 1. 
Structures of ginsenosides Rb1 and Rg1. (Adapted from [5]).
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to the number and position of sugar moieties on the sterol chemical structure. it 
is difficult to clarify the influence of the sugar moiety at different positions on 
pharmacological actions [14].
2.2 ADME of ginsenosides
Absorption, distribution, metabolism and excretion (ADME) describe the 
pharmacokinetics and pharmacodynamics of a single or more compounds in an 
organism such as human, mouse etc. The knowledge of pharmacokinetics of ginsen-
oside and its metabolites is very imperative in designing an optimal dosage regimen 
and minimizing the adverse effect that may result from ginseng-drugs interaction. 
The polar ginsenosides include Rg1, Re, Rb1, Rc, Rb2, Rb3, and Rd., while less polar 
ginsenosides include Rg2, Rg3, Rg5, Rh2, Rk1, and Rs4 [15, 16]. Protopanaxadiol 
ginsenosides are metabolized to ginsenoside compound K by the intestinal micro-
flora in humans. Ginsenoside compound K (20-O-β-D-glucopyranosyl-20(S)-
protopanaxadiol), is found in the blood stream of humans as an active metabolite 
after oral administration of protopanaxadiol ginsenosides Rb1, Rb2, Rc, and Rd., 
and has significantly higher mean maximum plasma concentration and significantly 
lower half-life when compare to the ginsenoside Rb1 [17].
According to Qi et al., [18], the ginseng saponins have low absorption rate and 
characterized by extensive metabolism in the gastrointestinal tract, poor membrane 
permeability, and low solubility of deglycosylated products; and with less than 5% 
dose bioavailability of the protopanaxadiol (PPD) group of saponins (ginsenosides 
Ra3, Rb1, Rd., Rg3, and Rh2) and of the protopanaxatriol (PPT) group of saponins 
(ginsenosides Rg1, Re, Rh1, and R1) were less than 5%. However, PPT saponins have 
better bioavailability than PPD saponins, which may be due to the fact that PPD 
saponins degrade faster than PPT saponins. Study on ginseng absorption by HPLC 
analysis, showed that Rb1 (4.35%) and Rg1 (18.40%) were absorbed, respectively [19].
Study on the effect of American ginseng and Asian ginseng extracts on gene 
expression of the hepatic cytochrome P450 enzyme in elderly humans, has shown 
that protopanaxadiol (PPD), protopanaxatriol (PPT) and their metabolites, 
moderately inhibited CYP2C9 activity and strongly inhibited CYP3A4 activity  
[20, 21]. Henderson et al., [22] have studied the effects of seven naturally occur-
ring ginsenosides Rb1, Rb2, Rc, Rd., Re, Rf, and Rg1 and eleutherosides B and 
S.No Constituents References
1. Ginsenine [24]
2 betasitosterol, 20(R)-protopanaxatriol, daucosterin,
20(R)-ginsenoside-Rg3
[25]
3 isoginsenoside-Rh(3), ginsenoside-Rb(1), -Rb(2), −Rc, −Rd, -Re, − Rg(1), 
-Rh(1), -Rh(2).
[26]
4 Daucosterin; 20(R)-dammarane-3beta,12beta,20,25-tetrol  
(25-OHPPD); 20(R)-dammarane-3beta,6alpha,12beta,20,25-pentol 
(25-OH-PPT); 20(S)-protopanaxadiol (PPD); 20(S)-ginsenoside-Rh(2) 
(Rh2); 20(S)-ginsenoside-Rg(3) (Rg3); 20(S)-ginsenoside-Rg(2) 




5 Panaxadione, ginsenosides Rd., Re, and Rg2 [28]
Table 1. 
Chemical constituents of P. ginseng.
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E (active components of the ginseng root) on the catalytic activity of cDNA 
expressed CYPs (CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) in in vitro 
experiments. They found that the ginsenosides and eleutherosides tested are not 
likely to inhibit the metabolism of co-administered medications in which the 
primary route of elimination is via cytochrome P450 [22]. Comprehensive review 
of the ginseng active compounds pharmacokinetics, drug–drug interaction, and 
influence of cytochrome P450 has been published [23]. Chemical constituents of P. 
ginseng and mechanisms of selected ginseng compounds are shown in Table 1 and 2 
respectively.
3. Bioinformatics analyses of ginsenosides
A study has proposed a novel method to explore underlying mechanisms of 
multiple actions of multiple constituents of Ginseng (Panax ginseng) against 
cancers, and the bioinformatics analyses was initiated with proteins regulated by 
ginsenoside rb1/re/rg1, using standard tools such as ChEMBL, STRING, DAVID 
and KEGG [43].
In the study conducted by Yan et al. [44] to identify immunomodulatory bio-
markers in an immune cell induced by ginseng, microarray assays were carried out 
to identify differentially expressed genes associated with American ginseng (Panax 
quinquefolius) exposure to 4 groups of Murine splenic cells from adult male C57BL/6 
(B6) mice which were isolated to mimic 4 basic pathophysiological states. The 
microarray data obtained was analyzed with Partek Genomics Suite software while 
DAVID Bioinformatics Resources 6.7 was used for functional annotation clustering. 
The effect of American ginseng on the interferon gamma signaling functions was 
obtained by the use of Interferome software [44].
In their study, Zhu et al. [8], have reported two major Panax ginseng glycoprotein 
(PGG-1 and PGG-2) obtained by high performance liquid chromatography, with 
S.No Ginsenoside Mechanism Reference
1 Rb1 protects hippocampal neuron, enhance insulin/IGF-1 
signaling, inhibited GSK-3β-mediated C/EBP homologous 
protein (CHOP) signaling
[29–32]
2 Rb2 Down-regulation of matrix metalloproteinase
(MMP)-2
[33]
3 Rg1 Downregulation of nuclear factor-kappa B (NF-𝜅B)/nitric 
oxide (NO) signaling pathway, increases the expression of 
insulin growth factor I receptor (IGF-IR)
[34–35]
4 Rd Phosphoinositide-3-kinase/AKT and phosphoextracellular 
signal-regulated protein kinase (ERK) 1/2 pathways, suppress 
poly(ADP-ribose) polymerase-1, protein tyrosine kinase 
activation, the upregulation of the endogenous antioxidant 
system and GAP-43 expression
[5, 36, 37]
5 Re PREVENT the reduction of H(+)-ATPase activity [38]
6 Rg3 Modulation of three modules of MAP kinases, P-gp 
(P-glycoprotein) inhibition, modulation of Ephrin 
receptor pathway, inhibits NMDA receptor by increasing 




The molecular mechanism of ginsenosides pharmacological activities.
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the molecular weights of 1.5 KDa and 8.2 KDa respectively calculated by gel perme-
ation chromatography. The ginseng samples were analyzed by LC–MS using a nano-
flow RP-HPLC online-coupled to a Q Exactive mass spectrophotometer operating 
in the positive ion mode. The raw MS files were analyzed and searched against the 
UniProt ginseng protein sequence database using Byonic software (Version 2.3.5). 
The computed parameters of PGG determined by MS include theoretical isoelectric 
point (pI), instability index, aliphatic index and grand average of hydropathicity 
(GRAVY). The aliphatic index of PGG-1 ranged from 0 to 130, with an average of 
48.23; the aliphatic index of PGG-2 ranged from 61.25 to 195.71, with an average of 
129.41 [8].
Bioinformatics network analysis has been used to analyzed a combination of 
ginseng and arginine regimen, ginseng and lingzhi as well as ginseng and gingko 
regimens [45, 46], in order to understand potential impact of drug–drug interaction 
(agonism or antagonism) based on common pathways.
3.1  In silico target prediction and gene expression network of key ginseng 
constituents
The ligands (Ginsenoside Rb1, Rc, Rg3, Re, F1, C; Betasitosterol, Panaxadione,  
Daucosterin (also known as Sitogluside or Eleutheroside A), and 20(R)- 
protopanaxatriol) were subjected to in silico target prediction on Swiss 
TargetPrediction server where Homo sapiens was selected as target organism [47] 
as shown in Table 3. Forty-five (45) genes (PTAFR, IL2, STAT3, VEGFA, FGF1, 
FGF2, HPSE, PSEN1, PSENEN, NCSTN, BCL2L1, PRKCA, HSD11B1, CYP19A1, 
SIRT2, PTPN1, CCR1, VDR, PTPN11, NR1I2, REN, BACE1, NR3C1, INSR, ITK, 
S.No Constituents Target Genes % probability Possible effect
1 Ginsenoside Rb1, Rg3, 
Rc, Re, F1, C,
PTAFR, IL2, STAT3, 
VEGFA, FGF1, FGF2, 





2 Panaxadione PRKCA, HSD11B1, 
CYP19A1, SIRT2, PTPN1, 
CCR1, VDR, PTPN11, 
NR1I2, REN, BACE1, 
NR3C1, INSR, ITK, F2R
20 Anti-inflammatory, 
anti-diabetic







4 Daucosterin STAT3, IL2 20–60 Immunomodulatory, 
anti-cancer, 
anti-inflammatory
5 20(R)-protopanaxatriol PTPN1, CYP2C19, 
CHRM2, SLC6A2, 
SLC6A4, AR, ACHE, 







Predicted genes of selected Ginseng constituent.
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F2R, AR, HMGCR, CYP51A1, NPC1L1, NR1H3, CYP19A1, CYP17A1, RORC, ESR1, 
ESR2, CYP2C19, CHRM2, SLC6A2, SLC6A4, ACHE, HSD11B1, ATP12A, HMGCR, 
CYP51A1) were extracted from the predicted targets and subjected to expression 
network analyses (transcription factor enrichment analysis, protein–protein 
interaction network expansion and kinase enrichment analysis), using eXpres-
sion2Kinases (X2K) Web server [48] as shown Figures 2-5.
The genes that were targeted by Betasitosterol (Table 3) have greater than 30% 
probability (35–70%), Daucosterin targeted Interleukin-2 (IL2) with 60% probabil-
ity, while others were less than 30%. The best target of Betasitosterol is Androgen 
Receptor (AR), followed by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) 
reductase, Cytochrome P450 51, Niemann-Pick C1-like protein 1, LXR-alpha, 
Cytochrome P450 19A1, Cytochrome P450 17A1, Nuclear receptor ROR-gamma 
and others.
This study shows that SUZ12 has the highest score as transcription factor 
influenced by the ginseng, this is followed by STAT3, RUNX1, FOS, VDR, RCOR1, 
Figure 2. 
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SPI1 and EGR1 (Figures 2 and 3). The kinases that were impacted by the action of 
ginseng active constituents include MAPK1, MAPK14, AKT1, CDK1, ABL1, ERK1 
and ERK2 (Figure 4). Moreover, major intermediate proteins JUN, RARA, NCOR1, 
MYC, RB1, HDAC2, CSNK2A1 and others (Figure 5).
Zhang et al. [49] have reported ginsenoside, stigmasterol, β-sterol, β-elemene 
and β-selinene, kaempferol, panaxynol, ginsenoyne A, fumarine, girinimbin, 
elemicin, dauricine, and maltol, as part of secondary metabolites produced by gin-
seng. However, network analysis of ginseng-associated targets ginseng in treatment 
of depression which could occur in post-COVID19 period, identified AKT1, CASP3, 
NOS3, TNF, and PPARG as the core genes in protein–protein interaction network, 
Figure 4. 





and that ginsenoside Re, ginsenoside Rg1, frutinone A and kaempferol were the key 
ingredients in ginseng for immune-regulation [50].
Based on curated data on UniProt database (www.uniprot.org), androgen 
receptor (Uniprot ID: P10275) involves in positive regulation of MAPK cascade, 
NF-kappaB transcription factor activity, insulin-like growth factor receptor signal-
ing pathway, and transcription by RNA polymerase II and III, as well as negative 
regulation of transcription by RNA polymerase II, epithelial cell proliferation, and 
extrinsic apoptotic signaling pathway. HMG-CoA reductase (UniProt ID: P04035) 
involves in positive regulation of ERK1 and ERK2 cascade, stress-activated MAPK 
cascade, cardiac muscle cell apoptotic process, smooth muscle cell proliferation, 
and cholesterol homeostasis, as well as negative regulation of MAP kinase activity, 
wound healing, and striated muscle cell apoptotic process, and it also give response 
to ethanol. Interleukin-2 (UniProt ID: P60568) involves in positive regulation of 
inflammatory response, transcription by RNA polymerase II, tyrosine phosphoryla-
tion of STAT protein, interferon-gamma production, B cell and activated T cell 
proliferation and immunoglobulin secretion, as well as negative regulation of 
inflammatory response, heart contraction, B cell apoptotic process, and lympho-
cyte proliferation, and it also give response to ethanol.
A comprehensive review of betasitosterol has reported several therapeutic 
potentials which include antioxidant, antipyretic, anti-inflammatory, anti-arthritic, 
and antimicrobial activities, as well as anti-cancer, anti-diabetic, antihyperlip-
idemic, anti-atherosclerosis, anti-pulmonary tuberculosis, angiogenic, immune 
modulation and anti-HIV effects [51].
4. Conclusion
Knowledge of bioinformatics has not been fully applied to the study of ginseng 
in proportionality to the acclaimed medicinal properties from the ethnobotan-
ical use.
This study has applauded Betasitosterol and Daucosterin as ginseng bioactive 
constituents that have several potential pharmacological effects in human, by 
modulating several proteins which include androgen receptor, HMG-CoA reduc-
tase, interlukin-2, and consequently impact the signaling cascade of several kinases 
such as Mitogen-activated protein kinases (MAPKs), as well as many transcription 
factors such as Polycomb protein SUZ12. Moreover, difference in pharmacological 
outcome of aqueous ginseng extract and ethanolic ginseng extract would neces-
sitate holistic approach of extraction. Furthermore, chemical biology and in silico 
simulation of pharmacological potential of ginseng bioactive compounds (such 
as molecular docking and dynamics, drug–drug interaction) will yield significant 
insights to the presently unexplored molecular mechanisms of action to explain the 
therapeutic effect of ginseng.
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